Chair of the Board · Monopar Therapeutics (MNPR)

Christopher M. Starr, Ph.D — Monopar Therapeutics Director Compensation (2025)

Fiscal year 2025 director compensation for Christopher M. Starr, Ph.D at Monopar Therapeutics. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 30, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Christopher M. Starr, Ph.D’s full pay file as a PDF — free

More than this page: up to 10 years of Christopher’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Christopher M. Starr, Ph.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Monopar Therapeutics Director Compensation Table · all 4 fiscal years held
In US dollars, as Monopar Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$80,000$0$336,724$120,000$536,724
FY2024$80,000$0$0$120,000$200,000
FY2023$80,000$32,020$32,021$120,000$264,041
FY2021$80,000$20,464$20,464$40,000$160,928

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Monopar Therapeutics DEF 14A filed April 30, 2026, accession 0001437749-26-014183, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Monopar Therapeutics filed document, accession 0001437749-26-014183. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.

Get the Monopar Therapeutics Board Governance Report

$536,724 Christopher M. Starr, Ph.D, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 30, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Monopar Therapeutics pays directors a $40,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Plan Administrator

The rest of the Monopar Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Arthur J. KlausnerIndependent Director$401,224
Chandler D. Robinson, MDDirector—
Kim R. TsuchimotoIndependent Director$389,937
Lavina TalukdarIndependent Director$225,331
Nicole SweenyIndependent Director—
Raymond W. AndersonIndependent Director$409,224

The full Monopar Therapeutics compensation record

free company brief

This page is one director within Monopar Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order MNPR

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report